Cargando…

The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy

Between January 2017 and July 2018 103 patients were included in a prospective study of erythropoietin (EPO) monitoring. The group consisted of 33% patients with oropharynx, 29% with oral cavity, 13% with nasopharynx, 6% with larynx, 6% with hypopharynx, 8% with unknown primary cancer, 4% with nasal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leś, Dominika, Saduś-Wojciechowska, Maria, Rutkowski, Tomasz, Wygoda, Andrzej, Składowski, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883964/ https://www.ncbi.nlm.nih.gov/pubmed/31798335 http://dx.doi.org/10.5114/wo.2019.89247

Ejemplares similares

Low dose radiotherapy as an effective treatment in a patient with solitary Wegener's granulomatosis resistant to systemic treatment – case report
por: Wygoda, Andrzej, et al.
Publicado: (2013)

The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer
por: Rutkowski, Tomasz W., et al.
Publicado: (2014)

Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue
por: Widłak, Piotr, et al.
Publicado: (2013)

Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma
por: Butkiewicz, Dorota, et al.
Publicado: (2022)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
por: Brewczyński, Adam, et al.
Publicado: (2020)

Dermoscopy of acute radiation-induced dermatitis in patients with head and neck cancers treated with radiotherapy
por: Pilśniak, Aleksandra, et al.
Publicado: (2023)

The Association between Carotenoids and Head and Neck Cancer Risk
por: Brewczyński, Adam, et al.
Publicado: (2021)

Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2020)

Erythrocytes and Erythropoietin
por: Föller, Michael, et al.
Publicado: (2011)

DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients
por: Butkiewicz, Dorota, et al.
Publicado: (2023)

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
por: Thyss, A., et al.
Publicado: (1986)

Radiation-Induced Changes in Serum Lipidome of Head and Neck Cancer Patients
por: Jelonek, Karol, et al.
Publicado: (2014)

Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients—Comparison of Serum Metabolome Profiles
por: Jelonek, Karol, et al.
Publicado: (2020)

High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
por: Polanowski, Paweł, et al.
Publicado: (2022)

Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer
por: Rutkowski, Tomasz W., et al.
Publicado: (2020)

Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics
por: Boguszewicz, Łukasz, et al.
Publicado: (2021)

Results of Primary Treatment and Salvage Treatment in the Management of Patients with Non-Squamous Cell Malignant Tumors of the Sinonasal Region: Single Institution Experience
por: Kacorzyk, Urszula, et al.
Publicado: (2023)

NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients
por: Boguszewicz, Ł., et al.
Publicado: (2019)

From Anemia to Erythropoietin Resistance in Head and Neck Squamous Cell Carcinoma Treatment: A Carousel Driven by Hypoxia
por: Lazzari, Grazia, et al.
Publicado: (2020)

Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic
por: Krajewska (Wojciechowska), Joanna, et al.
Publicado: (2020)

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

The role of tumor volume in radiotherapy of patients with head and neck cancer
por: Rutkowski, Tomasz
Publicado: (2014)

Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023)

Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting
por: Yasuoka, Yukiko, et al.
Publicado: (2020)

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
por: Siano, Marco, et al.
Publicado: (2017)

PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
por: Shen, Bin, et al.
Publicado: (2019)

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro
por: Abhold, Eric, et al.
Publicado: (2011)

Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation
por: Frankiewicz, Andrzej, et al.
Publicado: (2018)

The Oncogenic Roles of PTTG1 and PTTG2 Genes and Pseudogene PTTG3P in Head and Neck Squamous Cell Carcinomas
por: Grzechowiak, Inga, et al.
Publicado: (2020)

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck
por: Posner, M R, et al.
Publicado: (2003)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

Roles of Coactivators in Hypoxic Induction of the Erythropoietin Gene
por: Wang, Feng, et al.
Publicado: (2010)

Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma
por: Fang, Xiao-Nan, et al.
Publicado: (2018)

Endogenous erythropoietin at birth is associated with neurodevelopmental morbidity in early childhood
por: Rancken, Elina J., et al.
Publicado: (2021)

Induction of Erythrocyte Shrinkage by Omeprazole
por: Naveed, Ayesha, et al.
Publicado: (2020)

An Erythropoietin-Independent Mechanism of Erythrocytic Precursor Proliferation Underlies Hypoxia Tolerance in Sea Nomads
por: Ilardo, Melissa, et al.
Publicado: (2022)

Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients
por: Hasegawa, Shun, et al.
Publicado: (2021)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_punnti8r18lr5710i93phs9c3t